Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001133416-22-000010
Filing Date
2022-01-19
Accepted
2022-01-19 11:18:30
Documents
1
Period of Report
2022-01-19

Document Format Files

Seq Description Document Type Size
1 form4.html 4/A  
1 form4.xml 4/A 4499
  Complete submission text file 0001133416-22-000010.txt   5951
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 712 LAKEWAY DRIVE KELLER TX 76248
Business Address
FREEMAN KEVIN D (Reporting) CIK: 0001522478 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-31791 | Film No.: 22537369